Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

被引:20
|
作者
Caritis, Steve N. [1 ]
Simhan, Hyagriv N. [1 ]
Zhao, Yuan [16 ]
Rouse, Dwight J. [2 ,3 ]
Peaceman, Alan M. [4 ]
Sciscione, Anthony [5 ]
Spong, Catherine Y. [17 ]
Varner, Michael W. [6 ]
Malone, Fergal D. [7 ]
Iams, Jay D. [8 ]
Mercer, Brian M. [9 ]
Thorp, John M., Jr. [10 ]
Sorokin, Yoram [11 ]
Carpenter, Marshall [12 ]
Lo, Julie [13 ]
Ramin, Susan M. [14 ]
Harper, Margaret [15 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA
[2] Univ Alabama Birmingham, Dept Obstet, Med Sch Birmingham, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Gynecol, Med Sch Birmingham, Birmingham, AL USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[6] Univ Utah, Sch Med, Salt Lake City, UT USA
[7] Columbia Univ, Coll Phys & Surg, New York, NY USA
[8] Ohio State Univ, Ohio State Coll Med, Cleveland, OH USA
[9] Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Cleveland, OH USA
[10] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[11] Wayne State Univ, Sch Med, Detroit, MI USA
[12] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[13] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[14] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[15] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[16] George Washington Univ, Ctr Biostat, Washington, DC USA
[17] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
关键词
17-hydroxyprogesterone caproate; pharmacodynamics; twin gestation; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; PREMATURITY; PREVENTION;
D O I
10.1016/j.ajog.2012.08.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. STUDY DESIGN: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. RESULTS: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P < .001). Women receiving 17-OHPC demonstrated significantly higher (P = .005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P < .0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. CONCLUSION: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Effect of formulation and route of administration on the distribution of 17-hydroxyprogesterone caproate in rats
    Shaik, Imam H.
    Chaphekar, Nupur
    Vasudevan, Vignesh
    Alshabi, Ali
    Bastian, Jaime R.
    Zhao, Wenchen
    Caritis, Steve
    Venkataramanan, Raman
    XENOBIOTICA, 2023, 53 (03) : 193 - 200
  • [32] The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies
    Gyamfi, Cynthia
    Horton, Amanda L.
    Momirova, Valerija
    Rouse, Dwight J.
    Caritis, Steve N.
    Peaceman, Alan M.
    Sciscione, Anthony
    Meis, Paul J.
    Spong, Catherine Y.
    Dombrowski, Mitchell
    Sibai, Baha
    Varner, Michael W.
    Iams, Jay D.
    Mercer, Brian M.
    Carpenter, Marshall W.
    Lo, Julie
    Ramin, Susan M.
    O'Sullivan, Mary Jo
    Miodovnik, Menachem
    Conway, Deborah
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (04) : 392.e1 - 392.e5
  • [33] Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth
    Ning, Angela
    Vladutiu, Catherine J.
    Dotters-Katz, Sarah K.
    Goodnight, William H.
    Manuck, Tracy A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (03) : 371.e1 - 371.e7
  • [34] Metabolism of 17-hydroxyprogesterone caproate by the dually perfused human placental lobule
    Hemauer, Sarah
    Yan, Ru
    Patrikeeva, Svetlana
    Mattison, Donald
    Hankins, Gary D. V.
    Ahmed, Mahmoud
    Nanovskaya, Tatiana
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S45 - S45
  • [35] Route of administration and formulation dependent pharmacokinetics of 17-hydroxyprogesterone caproate in rats
    Shaik, Imam H.
    Bastian, Jaime R.
    Zhao, Yang
    Caritis, Steve N.
    Venkataramanan, Raman
    XENOBIOTICA, 2016, 46 (02) : 169 - 174
  • [36] The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
    Ransom, Carla E.
    Chin, Jeanette R.
    Roeder, Hilary A.
    Sinclair, Tammy R.
    Heine, R. Phillips
    Murtha, Amy P.
    JOURNAL OF PREGNANCY, 2011, 2011 : 286483
  • [37] Fetal Fibronectin versus Cervical Length as Predictors of Preterm Birth in Twin Pregnancy with or without 17-Hydroxyprogesterone Caproate
    Combs, C. Andrew
    Garite, Thomas J.
    Maurel, Kimberly
    Das, Anita
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (12) : 1023 - 1029
  • [38] BLOODSPOT 17-HYDROXYPROGESTERONE CONCENTRATIONS IN PRETERM INFANTS
    GOTTEINER, NL
    DAVIS, CL
    SILVERMAN, BL
    CLINICAL RESEARCH, 1989, 37 (04): : A960 - A960
  • [39] The impact of prior gestational age at preterm delivery on the effectiveness of 17 alpha-hydroxyprogesterone caproate (17OHPC) in clinical practice
    Quintero, Victor Hugo Gonzalez
    de la Torre, Lesley
    Istwan, Niki
    Rhea, Debbie
    Tudela, Carmen Maria
    Vazquez-Vera, Enrique
    Stanziano, Gary
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S57 - S57
  • [40] A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity
    Awwad, J.
    Usta, I. M.
    Ghazeeri, G.
    Yacoub, N.
    Succar, J.
    Hayek, S.
    Saasouh, W.
    Nassar, A. H.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (01) : 71 - 79